Scientific Sessions (updated June 2, 2014)

Plenary Sessions | Meet-The-Experts | Pre-Congress Symposium |
| Symposia & Oral Presentations : Thursday | Friday | Saturday |

PLENARY SESSIONS
Thursday, April 3, 2014

Plenary I
Plenary II
  • Community-Directed Treatment of NTDs: Research to Community Action
    Uche Amazigo (Nigeria)
    Thursday, April 3, 2014, 14:30 - 15:15hrs
    16thICID_Amazigo.pdf (3.8 MB)
Friday, April 4, 2014

Plenary III
  • Old and New Global Challenges in Infectious Diseases
    Peter Piot (United Kingdom)
    Friday, April 4, 2014, 9:00 - 9:45hrs
Plenary IV
  • Otitis Media as an Infectious Disease: The Debate Goes On
    Ron Dagan (Israel)
    Friday, April 4, 2014,14:30 - 15:15hrs
    16thICID_Dagan2.pdf(2.5 MB)
Saturday, April 5, 2014

Plenary V
  • Influenza: Understanding Pathogenesis to Improve Outcomes
    Jonathan McCullers (USA)
    Staurday, April 5, 204, 9:00 - 9:45hrs
    16thICID_McCullers.pdf (712 kB)
Plenary VI
  • MERS-COV
    Ziad Memish (Saudi Arabia)
    Saturday, April 5, 2014, 14:30 - 15:15hrs

return to top

MEET-THE-EXPERTS
Thursday, April 3, 2014
  • Invasive Non-typhoid Salmonellosis (iNTS): Increasing Awareness and Future Vaccines
    Thursday, April 3, 2014,  07:45-08:45hrs
    "An Overview of iNTS Epidemiology"
    Myron Levine (USA)

    "Bivalent Vaccine Strategies for Invasive Non-typhoidal Salmonella Infections"
    Sharon Tennant (USA)
  • Prevention and Management of UTI and Urosepsis
    Thursday, April 3, 2014,  07:45-08:45hrs
    Kurt Naber (Germany)
  • The World Organisation for Animal Health (OIE) system for recognising disease free status of member countries: Can the Rinderpest eradication be replicated for Mad Cow Disease?
    Thursday, April 3, 2014,  07:45-08:45hrs
    Gideon Brueckner (South Africa)
Friday, April 4, 2014
  • The Use of Viral Load Monitoring and Virus Genotyping in the Management of Hepatitis
    Friday, April 4 2014,  07:45-08:45hrs
    RK Ratho (India)
  • 20 years of Antibiotic Prescribing, Real World Data Analysis
    Friday, April 4 2014,  07:45-08:45hrs
    supported by an educational grant from Abbott
    Ross Davidson (Canada)
  • Publishing your Work: Perspectives From the Editor in Chief of IJID and Associate Editor of EID
    Friday, April 4, 2014, 07:45-08:45hrs
    Eskild Petersen (Denmark)
    Sharon Bloom (USA)
Saturday, April 5, 2014

  • Research Funding Opportunities at the Wellcome Trust: How to Write a Successful Application
    Saturday, April 5, 2014, 07:45-08:45hrs
    Laura Bethke (UK)
    Dermot Maher (UK)
  • Sexually Transmitted Infections: Vaccine Development forGlobal Health
    Saturday, April 5, 2014, 07:45-08:45hrs
    "Introduction of the Special Issues of the journal Vaccine on STI Vaccines and How STI Vaccine Development Responds to the Decade of Vaccine Agenda"
    Helen Rees (South Africa)

    "Key Scientific Gaps and Overarching Issues Towards the Development of STI Vaccine"
    Sinead Delany-Moretlwe (South Africa)

    "How to Bridge the Gap: The Way Towards the Availability of STI Vaccines"
    David Lewis (South Africa)

return to top

PRE-CONGRESS SYMPOSIUM
Wednesday, April 2, 2014

Emerging Young African Investigators Symposium
Wednesday, April 2, 2014, 13:00-17:00hrs
Supported by the Clinical Infectious Diseases Research Initiative at the University of Cape Town and The Wellcome Trust
  • What are the risks of emergence of chikungunya outbreak in Central African Republic?
    B. Kamgang (Central African Republic)
  • First evidence of circulation of Chikungunya virus in Mozambique
    E.S. Gudo (Mozambique)
  • Using network analysis technique to describe the spread of Marburg hemorrhagic fever outbreak in Uganda, 2012
    L. Nyakarahuka (Uganda)
  • Molecular evolution of Zika virus during its emergence in the 20th century
    O. Faye (Senegal)
  • Dengue fever outbreak in Mogadishu, Somalia 2011: Co-circulation of three dengue virus serotypes
    H. Kyobe Bosa (Somalia)
  • The vector competence of Ae. aegypti mosquito populations from Kilifi and
    Nairobi for dengue-2 virus and the effect of temperature<br />
    E. Chepkorir (Kenya)
  • Bacteriuria and urinary schistosomiasis in primary school children in rural communities in Enugu State, Nigeria, 2012
    O. Ossai (Nigeria)
  • Anopheles fauna and entomological innoculation rates in the health district of Pitoa, North Cameroon
    A.B. Njeambosay (Cameroon)
  • RDT are more cost effective to detect asymptomatic Plasmodium falciparum infection which is associated with anemia in pregnancy, Kinshasa, Democratic Republic of the Congo
    J.R. Matangila (Republic of Congo)
  • Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia
    M.E. Seid (Ethiopia)
  • RNA-Seq reveals strain-specific immune gene expression by epithelial cells infected with Mycobacterium tuberculosis strains of varying pathogenicity
    N.E. Mvubu (South Africa)
  • Synergistic ablation of TNF in myeloid and lymphoid T cell subsets is a signature of CNS M.tuberculosis infection
    N.M. Francisco (South Africa)
  • Efficacy of early treatment of acute hepatitis C infection with pegylated interferon
    N. Amina (Uganda)
  • Evidence for shifting hepatitis B virus population epidemiology after nearly two decades of universal hepatitis B vaccination in South Africa
    J. Mphahlele (South Africa)
  • Virological profiles of hepatitis B virus (HBV)-infected African patients treated with tenofovir
    H.F. Njai (The Gambia)
  • Sero-epidemiology of major blood-borne infections among first time blood donors in Edea, Cameroon
    N.J.R. Nansseu (Cameroon)
  • Comparison of quantitative real-time PCR assay and direct immunofluorescence test for the detection of P. jirovecii infection versus colonisation
    B. Poonsamy (South Africa)
  • The prevalence and incidence of diabetes mellitus and other disorders of glycaemia in South African black patients on antiretroviral therapy
    N.P. Magula (South Africa)

return to top

SYMPOSIA & ORAL PRESENTATIONS
Thursday, April 3, 2014

Spotlight on Africa
Thursday, April 3, 2014, 10:15-12:15hrs

Grand Challenges in Malaria
Thursday, April 3, 2014, 10:15-12:15hrs
  • Accelerating to Zero: Closing the Gap in Detection, Cure, and Transmission to Achieve Malaria Eradication
    A. Magill (USA)
    16thICID_Magill.pdf (1.9 MB)
  • Preventing the Global Spread of Artemisinin Resistance: Can We Subvert Evolution?
    P. Guerin (United Kingdom)
  • Novel Antimalarial Targets and the Antimalarial Pipeline
    K. Chibale (South Africa)
  • Insecticide Resistance: Will Mosquitoes Be our Nemesis?
    M. Coetzee (South Africa)

Diagnosis and Management of Drug-resistant Tuberculosis
Thursday, April 3, 2014, 10:15-12:15hrs
  • The Increase of Mycobacterium tuberculosis Drug Resistance in Low and Middle Income Countries
    W. Van Gemert (Switzerland)
    16thICID_van Gemert.pdf (2.1 MB)
  • New Developments in Rapid Diagnostics for Drug-resistant Tuberculosis
    M. Nicol (South Africa)
  • Newer and Novel insights into the Pathogenesis and Treatment of Drug-Resistant TB
    K. Dheda (South Africa)
  • Transmission, Prevention and Management of Drug Resistant Tuberculosis
    B. Marais (Australia)
    16thICID_Marais.pdf (3 MB)

Oral Presentations: Tropical Infectious Diseases
Thursday, April 3, 2014, 10:15-12:15hrs
  • Multi-epitope peptide vaccines for human lymphatic filariasis

    J. Madhumathi (India)

  • Understanding dengue transmission and risk factors through ecohealth approach in Bangladesh

    P. Dhar-Chowdhury (Canada)

  • Dengue virus surveillance in a medium size city in Brazil reveals a complex pattern of serotypes and strains circulation

    M. Nogueira (Brazil)

  • Detection of dengue virus in ten minutes using reverse transcription recombinase polymerase amplification assay
    A. Abd El Wahed (Egypt)
  • Induction of nAbs and protection of mice immunized with VLP's expressing CHIKV env

    K. Muthumani (USA)

  • Comprehensive genome-wide analysis of WDR superfamily of Plasmodium falciparum, cloning and production of PfWDR protein involved in chromatin remodelling
    R. Gill (USA)
  • Malaria transmission dynamics of the Anopheles mosquito in Kumasi, Ghana
    A.W. Basing (Ghana)
  • Risk factors of Rift Valley fever in central Sudan
    T. M. A. Elhassan (Sudan)
  • Opposing roles of host IFN-γ signaling during a parasite infection of the mouse

    N. Gupta (Germany)

  • Serological survey of leptospira infection in domestic and wild animals in Katavi ecosystem, Tanzania
    L. Matemba (Tanzania)

Implementing Antimicrobial Stewardship in an Era of Multidrug Resistance
Thursday, April 3, 2014, 10:15-12:15hrs
Supported by an educational grant from MSD
  • Antibiotic Use and the Trends of Gram negative Resistance Around the World
    A. Brink (South Africa)
  • Role of Antimicrobial Stewardship (AMS) and Startegies for Appropriate Therapy
    E. Goldstein (USA)
  • Pseudomonas Resistance in Hospital Setting; Why Pseudomonas Sparing is an Important AMS Strategy
    Y. Carmeli (Israel)
  • Practical Considerations for Implementing AMS in Hospitals
    M.V. Villegas (Colombia)

return to top


Childhood and Adult Pneumonia in the Era of Conjugate Vaccines
Thursday, April 3, 2014, 15:45-17:45hrs

Surveillance of Zoonotic Diseases
Thursday, April 3, 2014, 15:45-17:45hrs


Dengue: A Global Challenge
Thursday, April 3, 2014, 15:45-17:45hrs
In collaboration with the Latin American Society of Pediatric Infectious Diseases (SLIPE)

  • Etioepidemiology of Dengue in Latin America
    B. Zambrano (Venezuela)
    16thICID_Zambrano.pdf (2 MB)
  • The Spread of Dengue into Africa
    A. Sall (Senegal)
  • Prevention of Dengue Vaccines in the Pipeline
    L.C. Rey (Brazil)
    16thICID_Rey.pdf (1.6 MB)
  • Mediators of Vascular Leak in Dengue
    N. Malavige (Sri Lanka)

Infectious Diseases in Refugees and Migrants
Thursday, April 3, 2014, 15:45-17:45hrs
Supported by a NATO grant on Refugee and Migrant Health

HIV - Antiretroviral Therapy
Supported in part by an educational grant from Gilead Pharmaceuticals
Thursday, April 3, 2014, 15:45-17:45hrs

Oral Presentations: Hot Topics
Thursday, April 3, 2014,15:45-17:45hrs
  • Randomized, placebo-controlled trial on safety and efficacy of inactivated influenza vaccination of pregnant women in preventing illness in their infants

    S. Madhi (South Africa)

  • Clinical and epidemiologic characteristics of acute respiratory infections in Vietnamese children

    N. D. Tran (Vietnam)

  • Immunogenicity of monovalent type 1 oral poliovirus vaccine administered at short and standard intervals: A randomized controlled trial, Pakistan, March 2012-May 2013

    F. Mir (Pakistan)

  • Enhancing safety and efficacy of RNAi-based gene therapy for the treatment of chronic hepatitis B
    T. Michler (Germany)
  • Tropheryma whipplei in Senegal

    F. Fenollar (France)

  • Are infants protected from measles: an examination of antibodies in mother/infant pairs in Tianjin, China
    M. Boulton (USA)
  • MERS CoV infection - ecological investigations
    S.F. Fagbo (Saudi Arabia)
  • Outbreak investigation report of measles among children under five years in Katsina State, Northern Nigeria, January 2013

    U.L. Shehu (Nigeria)

  • Viewing human health through the lens of livestock health: Linked human and animal syndromic surveillance
    T. Mwangi (USA)
  • Viewing human health through the lens of livestock health: Linked human
    and animal syndromic surveillance
    M. Chayakulkeeree (THAILAND)

return to top


Friday, April 4 2014

Challenges and Controversies in Infection Prevention
Friday, April 4, 2014, 10:15 - 12:15hrs
  • Healthcare Personnel (HCP) Attire in Acute-care, Non-surgical Settings
    G. Bearman (USA)
    16thICID_Bearman.pdf (1.4 MB)
  • Horizontal vs. Vertical Infection Prevention Strategies
    M. Stevens (USA)
  • Understanding and Controlling an MRSA Outbreak Using Whole Genome Sequencing
    S. Harris (United Kingdom)
  • The Role of the Patient and Family in Infection Prevention
    A. Duse (South Africa)

Judicious Use of Antibiotics in the Community: Beyond Headlines to Clinical Solutions
Friday, April 4, 2014, 10:15-12:15hrs
Supported by an educational grant from GSK
  • Implication of Current Resistance Trends on Community-acquired Respiratory Tract Infection (CA-RTI) Management
    A. Brink (South Africa)
  • What Is ‘Judicious Use of Antibiotics’ and Is it Achievable in Children?
    R. Dagan (Israel)
  • Does Guideline Adherence Have a Positive Impact on the Outcome of Community-acquired Respiratory Tract Infection (CA-RTI)
    C. Feldman (South Africa)

Control and Elimination of Neglected Tropical Diseases in Africa
Friday, April 4, 2014, 10:15-12:15hrs
  • Shistosomiasis
    J. Utzinger (Switzerland)
    16thICID_Utzinger.pdf (1.8 MB)
  • Elimination of Lymphatic Filariasis: The Endgame and Challenges for Meeting the 2020 Target
    B. Koudou (United Kingdom)
  • Trachoma Control & Elimination in Africa
    T. Gebre (Ethiopia)
    16thICID_Gebre.pdf (1.9 MB)
  • Integrating NTD Control Progams: Successes and Challenges
    A. Garba (Niger)

Hot Topics in HIV
Friday, April 4, 2014, 10:15-12:15hrs
  • The Road to HIV Cure
    D. Persaud (USA)
  • Chronic Inflammation and its Role in HIV Pathogenesis
    P. Hunt (USA)
    16thICID_Hunt.pdf (2.0 MB)
  • HIV and Severe Bacterial Infections in Africa
    R. Heyderman (Malawi)
  • Should HIV and Tuberculosis Services be Integrated in Developing Countries?
    B. Harley (South Africa)
    16thICID_Harley.pdf (674 kB)


Intervention or Prevention: Management of Invasive Fungal Infections
Friday, April 4, 2014, 10:15-12:15hrs

Supported by an educational grant from MSD

  • Tracking Resistance to Antifungal Drugs for Candida Species
    J. Coetzee (South Africa)
  • IFI in Internal Medicine Departments
    F. Menichetti (Italy)
  • Early Empiric Therapy for Invasive Candidiasis
    E. Mueller (Germany)
  • Standards in Prophylaxis: Prevention of Invasive Aspergillosis in Patients with Hematologic Malignancies
    D. Kontoyiannis (USA)


Oral Presentations: Bacterial Infections
Friday, April 4, 2014, 10:15-12:15hrs

  • An outbreak of New Delhi Metallo-β-Lactamase-1 producing enterobacteriaceae: A case-control studys
    P. de Jager (South Africa)
  • Dam methylation influences P fimbriae expression and binding of fluoroquinolone-resistant UPEC
    P. Brown (Jamaica)
  • Molecular characterization of T. pallidum subsp. pertenue, the etiologic agent of yaws
    A. Pillay (USA)
  • Pregnancy associated listeriosis in England & Wales: a 21 year review of enhanced surveillance data
    A. A. Awofisayo (United Kingdom)
  • Taking antimicrobial stewardship initiatives to the next level: Development of a serious prescribing game for acute care
    E. Castro-Sánchez (United Kingdom)
  • Novel surveillance system demonstrates burden of enteric fever in India
    D.N. Thacker (India)
  • ESBL-producing Enterobacteriaceae colonization among pregnant women in community in Madagascar
    F. Chereau (France)
  • Identifying "Trojan horse" positions within tetM to neutralize tetracycline resistance
    A. A. Y. Abouelfetouh (USA)
  • Incidence and determinants of health care associated blood stream infections at a neonatal intensive care unit in Ujjain, India: Results of a prospective cohort study
    A. Pathak (India)
  • A decade of invasive meningococcal disease surveillance in South Africa: 2003-2012
    S. Meiring (South Africa)

return to top


Vaccine Success and Failures
Friday, April 4, 2014, 15:45-17:45hrs
  • Introducing New Vaccines: Challenges of Decision making and Lessons Learned from the Recent Hib Vaccine Introduction Experience
    R. Hajjeh (USA)
  • Vaccine Confidence and Public Trust as Drivers of Vaccine Failure
    H. Larson (United Kingdom)
    16thICID_Larson.pdf (3.4 MB)
  • Tuberculosis Vaccines
    W. Hanekom (South Africa)
  • The Challenge of Vaccinating in Emergency Settings: Policy and Advocacy Implications
    J. Cohn (USA)
    16thICID_Cohn.pdf (1.7 MB)

Nosocomial Infections in Low and Middle Income Countries
Friday, April 4, 2014, 15:45-17:45hrs

Enteric Fever: The Accelerated Agenda to Deliver Conjugate Vaccines
Friday, April 4, 2014, 15:45-17:45hrs
In collaboration with the Coalition against Typhoid (CaT)
  • Use of Multiple Modalities to Assess the Burden of Typhoid Fever in Pediatric Population of Bangladesh
    S. Saha (Bangladesh)
  • Invasive Salmonellosis in Nigerian Children
    S. Obaro (USA)
  • The Rapidly Re-emerging Burden of Endemic Typhoid Fever in the 21st Century: A Preventable By-product of Massive Urbanization in the Developing World
    R. Breiman (USA)
    16thICID_Breiman.pdf (3.6 MB)
  • Modeling the Potential Impact of Typhoid Conjugate Vaccines
    V. Pitzer (USA)

Tuberculosis in Children
Friday, April 4, 2014, 15:45-17:45hrs
  • New Diagnostics for Pulmonary Tuberculosis in Children
    H. Zar (South Africa)
  • Isoniazid Preventive Therapy (IPT) for HIV Infected Children: Impact on Incidence of Tuberculosis?
    C. Mitchell (USA)
    16thICID_Mitchell.pdf (1.3 MB)
  • Getting Drug Doses Right in Children with Tuberculosis
    H. McIlleron (South Africa)
    16thICID_McIlleron.pdf (1.1 MB)
  • Lost in Translation: What Next for Studies of New TB Vaccines for Children?
    B. Kampmann (United Kingdom)

Oral Presentations: HIV and Tuberculosis
Friday, April 4, 2014, 15:45-17:45hrs
  • Whole-genome sequencing for TB drug resistance determination
    S.V. Omar (South Africa)
  • Characteristics and treatment outcomes of MDR tuberculosis in Taiwan
    R. Jou (Taiwan, ROC)
  • HIV and HBV infection in Cameroonian University context: Case of the University of Dschang
    J.-F. Onohiol (Cameroon)
  • HIV/AIDS knowledge improvement among Iranian prisons: Innovative Peer Education Method (FMP)
    Z. Vaezi (Iran)
  • Prevalence of primary tuberculosis among nomadic Fulani population and their cattle herds in Kano, Nigeria
    H. Muhammad (Nigeria)
  • Geospatial analysis and identification of space-time clusters of MDR-TB in South Africa, 2006-2012
    M. Mudau (South Africa)

  • Effect of nutritional counseling on LDL cholesterol among Thai HIV-infected adults

    S. Chotivichien (Thailand)

  • Tracking transfers: TB treatment completion among Ugandan prisoners
    A. Schwitters (USA)
  • Expression of the CCR5 HIV co-receptor in women with genital schistosomiasis
    E. Kleppa (Norway)
  • Evaluation of the Sensititre® MYCOTB MIC plate for susceptibility testing of Mycobacterium tuberculosis against the Etest and Agar proportion methods
    I. Rukasha (South Africa)

return to top


Saturday, April 5, 2014

Vaccines for Emerging and Re-emerging Public Health Threats
Saturday, April 5, 2014, 10:15-12:15hrs

Antibiotic Resistance - State of the Art
Saturday, April 5, 2014, 10:15-12:15hrs
In collaboration with the Japanses Association of Infectious Diseases (JAID)
  • Global Drivers of Antibiotic Resistanc
    S. Harbarth (Switzerland)
  • New Trends of the Treatment Strategy Against Infectious Diseases Caused by Antibiotic Resistant Bacteria
    Y. Ishii (Japan)
  • Carriage and Laboratory Detection of Multi-drug Resistant Bacteria in Low and Middle Income Countries
    P. Nordmann (France)
    16thICID_Nordmann.pdf (3.8 MB)
  • Antibiotic Resistance and Virulence
    A. Brink (South Africa)

Gender Differences in Infectious Diseases
Saturday, April 5, 2014, 10:15-12:15hrs

Rickettsiosis in Africa
Saturday, April 5, 2014, 10:15-12:15hrs

return to top


Pediatric/Adolescent HIV
Supported in part by an educational grant from Gilead Pharmaceuticals
Saturday, April 5, 2014, 10:15-12:15hrs
  • Can Pediatric HIV Be Eliminated?
    G. Gray (South Africa)
  • Infections in HIV-exposed Uninfected Infant: Under-appreciated but a Growing Concern
    M. Cotton (South Africa)
  • Second and third line treatment for pediatric patients failing ART
    M. Penazzato (Switzerland)
    16thICID_Penazzato.pdf (1.2 MB)
  • The Emerging Challenge of Managing HIV-infected Adolescents
    R. Ferrand (United Kingdom)

Towards Cholera Elimination: a New Era for an Integrated Strategy

Supported by an educational grant from the Initiative against Diarrheal and Enteric Diseases (IDEA)
Saturday, April 5, 2014, 10:15-12:15hrs

Tuberculosis: Hot Topics
Saturday, April 5, 2014, 15:45-17:45hrs
  • Tuberculosis Transmission Outside the Home
    R. Wood (South Africa)
  • The Interaction Between Antimicrobial and Adjunctive Therapies and the Immune Response to Tuberculosis
    R. Wilkinson (South Africa)
  • The Role of Vitamin D in Tuberculosis Pathogenesis and Treatment
    A. Martineau (United Kingdom)
  • New Drugs for the Treatment of Tuberculosis
    A. Diacon (South Africa)
    16thICID_Diacon.pdf (2.9 MB)

Antibiotic Stewardship
Saturday, April 5, 2014, 15:45-17:45hrs
In collaboration with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • Antimicrobial Stewardship: Opportunities and Challenges for Implementation
    B. Sinha (The Netherlands)
  • Social Media for Stewardship: Progress or a Waste of Time?
    D. Goff (USA)
    16thICID_Goff.pdf (1.4 MB)
  • Antifungal Stewardship
    C. Lass-Floerl (Austria)
  • Antimicrobial stewardship: Think Global, Act Local
    A. Gupta (India)
    16thICID_Gupta.pdf (3.1 MB)

Sexually Transmitted Infection Challenges for Africa
Saturday, April 5, 2014, 15:45-17:45hrs
  • HPV Vaccination Introduction into the African Region
    H. Rees (South Africa)
    16thICID_Rees.pdf (2.3 MB)
  • Containment of Antimicrobial Drug-resistant Gonorrhea
    D. Lewis (South Africa)
  • Mycoplasma Genitalium: The Missing Pathogen?
    J. Jensen (Denmark)
  • STIs in Men-who-have-sex-with-men: Can We Do Better?
    E. Sanders (Kenya)
    16thICID_Sanders.pdf (1.6 MB)

Traveling Bugs, Far and Wide
Saturday, April 5, 2014, 15:45-17:45hrs
  • Maha Kumbh Mela: Getting to Grips with Infectious Diseases and Public Health Threats at the Mother of All Mass Gatherings
    S. Balsari (USA)
    16thICID_Balsari.pdf (12 MB)
  • Expatriates in Africa: Repatriation Tales from the Bush
    A. De Frey (South Africa)
  • The Unexpected Traveling Companion: Interactive Cases in Migratory Helminthiases
    J. Frean (South Africa)
  • Postgraduate Training in Tropical Medicine: The Value of On-siteExperience
    D. Freedman (USA)

return to top